Press Ventures, Inc. (PVEN) Stock Analysis
DELISTED 2026
What happened to Press Ventures, Inc. (PVEN) stock?
Press Ventures, Inc. (PVEN) no longer trades on public markets. It was delisted in January 2026. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Press Ventures, Inc. (PVEN) trades at $0.00001. Press Ventures, Inc. focuses on owning rights to the cedar leaf oil diffusion (CLO-D) technology in Poland. The company aims to distribute its products through air conditioning installation companies. Sector: Basic materials.
Last analyzed: Mar 17, 2026Analyst Coverage for PVEN: PVEN does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates PVEN against Basic Materials peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
Press Ventures, Inc. (PVEN) Materials & Commodity Exposure
Press Ventures, Inc., based in Poland, owns the rights to CLO-D technology, which diffuses cedar leaf oil to eliminate bacteria and viruses. Targeting distribution via air conditioning companies, PVEN operates in the niche market of air purification within the basic materials sector.
What Is the Investment Thesis for PVEN?
Press Ventures, Inc. presents a speculative investment opportunity centered on its patented CLO-D technology for air purification. The company's success hinges on its ability to effectively commercialize and distribute its technology through air conditioning installation companies in Poland. Key value drivers include the adoption rate of CLO-D systems in commercial and residential buildings, the expansion of its distribution network, and potential partnerships with larger HVAC companies. However, the company's negative P/E ratio of -0.15 and a beta of -5.12 indicate significant volatility and financial risk. Growth catalysts include increasing awareness of air quality and potential government regulations promoting air purification technologies. Investors should carefully consider the risks associated with investing in an OTC-listed company with limited financial information.
Based on FMP financials and quantitative analysis
PVEN Key Highlights
Press Ventures, Inc. owns rights to the cedar leaf oil diffusion (CLO-D) technology in Poland.
- The patented CLO-D technology converts cedar leaf oil into a vapor to kill bacteria, mold, and viruses.
- The company distributes its products through a network of air conditioning installation companies.
- Press Ventures, Inc. was founded in 2010 and is based in Warsaw, Poland.
- The company has a negative P/E ratio of -0.15, reflecting current losses.
Who Are PVEN's Competitors?
PVEN is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| FALFF Falcon Metals Limited | $0.24 | +0.00% | $51.1M | 48 |
| GLHRF Golden Harp Resources Inc. | $0.10 | +0.00% | $5.80M | 50 |
| CMAUF Chibougamau Independent Mines Inc. | $0.11 | +0.00% | $6.79M | 49 |
| GSMGF Indiana Resources Limited | $0.02 | +0.00% | $12.5M | 63 |
| GDPHF Godolphin Resources Limited | $0.02 | +0.00% | $17.0M | 50 |
| DYNR DynaResource, Inc. | $0.63 | -19.23% | $18.5M | 51 |
| HMRRF Hammer Metals Limited | $0.03 | +0.00% | $26.8M | 55 |
| STRFF Star Royalties Ltd. | $0.36 | +5.83% | $28.6M | 50 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are PVEN's Key Strengths?
Patented CLO-D technology.
- Potential effectiveness against various pathogens.
- Distribution network of air conditioning installation companies.
- Focus on a growing air purification market.
What Are PVEN's Weaknesses?
Limited financial resources.
- Concentrated operations in Poland.
- Dependence on air conditioning installation companies for distribution.
- Negative P/E ratio indicates unprofitability.
What Could Drive PVEN Stock Higher?
Increasing awareness of air quality and health concerns.
- Potential government regulations promoting air purification technologies.
- Expansion into new geographic markets in Europe (2-3 years).
- Partnerships with HVAC manufacturers to integrate CLO-D technology (1-2 years).
What Are the Key Risks for PVEN?
Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Insider selling — insiders were net sellers of roughly $55.0M recently.
- Competition from established air purification companies with greater resources.
- Regulatory changes affecting air purification standards.
- Economic downturn impacting construction and HVAC spending.
- Limited financial resources and negative P/E ratio.
- OTC Other tier status and associated risks.
What Are the Growth Opportunities for PVEN?
- Expansion into New Markets: Press Ventures can expand its operations beyond Poland into other European countries with similar air quality concerns and regulatory environments. The European air purification market is projected to grow at a CAGR of 6% over the next five years, presenting a significant opportunity for PVEN to increase its revenue and market share. Timeline: 2-3 years.
- Partnerships with HVAC Manufacturers: Collaborating with major HVAC manufacturers to integrate the CLO-D technology into their systems could significantly increase its adoption rate. This would provide Press Ventures with access to a wider distribution network and enhance its credibility. The global HVAC market is estimated at $250 billion, offering a substantial opportunity for integration. Timeline: 1-2 years.
- Development of New Applications: The CLO-D technology can be adapted for use in various settings, including hospitals, schools, and public transportation. Developing specialized applications for these markets could create new revenue streams and diversify the company's customer base. The healthcare air purification market is expected to reach $5 billion by 2028. Timeline: 2-3 years.
- Licensing the CLO-D Technology: Licensing the CLO-D technology to other companies for use in their products or services could generate royalty income and expand its reach. This would allow Press Ventures to capitalize on its intellectual property without requiring significant capital investment. The licensing market for air purification technologies is estimated at $500 million annually. Timeline: Ongoing.
- Government Contracts and Subsidies: Pursuing government contracts and subsidies for air purification solutions in public buildings could provide a stable source of revenue and support the company's growth. Governments worldwide are increasingly investing in air quality initiatives, creating opportunities for companies like Press Ventures. Timeline: Ongoing.
What Are PVEN's Competitive Advantages?
- Patented CLO-D technology provides a barrier to entry.
- Established network of air conditioning installation companies in Poland.
- First-mover advantage in the Polish market.
- Proprietary knowledge of cedar leaf oil diffusion.
What Does PVEN Do?
Founded in 2010, Press Ventures, Inc. holds the rights to the cedar leaf oil diffusion (CLO-D) technology in Poland. This patented technology converts cedar leaf oil into a vapor, which is then diffused to kill bacteria, mold, and viruses, including Anthrax and the H1N1 virus. The company's primary focus is to distribute its CLO-D technology through a network of air conditioning installation companies, aiming to integrate its vapor diffusion systems into existing and new HVAC infrastructure. Based in Warsaw, Poland, Press Ventures operates within the basic materials sector, specifically targeting the air purification market. The company's strategy involves partnering with established air conditioning service providers to reach a wider customer base and ensure proper installation and maintenance of its CLO-D systems. While the company's operations are currently concentrated in Poland, there is potential for future expansion into other European markets. The effectiveness of the CLO-D technology against various pathogens is a key selling point, positioning Press Ventures as a provider of advanced air purification solutions.
What Products and Services Does PVEN Offer?
- Owns rights to the cedar leaf oil diffusion (CLO-D) technology in Poland.
- Converts cedar leaf oil into a vapor.
- Diffuses the vapor to kill bacteria, mold, and viruses.
- Targets Anthrax and H1N1 virus.
- Distributes products through air conditioning installation companies.
- Focuses on air purification in buildings.
How Does PVEN Make Money?
- Licensing the patented CLO-D technology.
- Selling CLO-D diffusion systems to air conditioning installation companies.
- Generating revenue through the sale of cedar leaf oil refills.
- Providing maintenance and support services for CLO-D systems.
What Industry Does PVEN Operate In?
Press Ventures, Inc. operates in the air purification market within the broader basic materials sector. The industry is characterized by increasing demand for air quality solutions, driven by health concerns and regulatory pressures. Competitors include companies offering traditional air filtration systems, UV-based purification technologies, and other vapor diffusion methods. The market is fragmented, with opportunities for innovative technologies like CLO-D to gain traction. However, Press Ventures faces competition from established players with greater resources and wider distribution networks. The growth of the air purification market is tied to factors such as urbanization, industrialization, and increasing awareness of indoor air pollution.
Who Are PVEN's Key Customers?
- Air conditioning installation companies in Poland.
- Commercial building owners seeking air purification solutions.
- Residential customers concerned about indoor air quality.
- Hospitals and healthcare facilities.
Financial Health
Press Ventures, Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
Key Financial Metrics
Return on equity for Press Ventures, Inc. stands at 132.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. Its free cash flow yield is -35.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
Company Profile
Press Ventures, Inc. operates in the Other Precious Metals industry within the Basic Materials sector. It is headquartered in Warsaw, US. The company is led by CEO Edward Denkiewicz. PVEN has traded publicly since 2012.
Insider Activity
The most recent 3 insider filings for Press Ventures, Inc. break down as 2 sales and 1 purchases. On net that is roughly 105.5M shares disposed (about $55.0M), a signal worth weighing alongside the fundamentals.
PVEN Financials
Bull Case vs Bear Case
Bull Case
- Community sentiment has turned positive, with discussions highlighting recent product innovations that could capture market interest.
- Analysts have noted an improved operational efficiency, which could lead to better profit margins and overall performance.
- The company has been actively engaging with its audience on social media, fostering a sense of community and loyalty among customers.
Bear Case
- Concerns over supply chain disruptions have been voiced in the community, potentially impacting production timelines and customer satisfaction.
- Recent earnings reports have shown mixed results, leading some investors to question the sustainability of growth.
- There are ongoing discussions about increased competition in the sector, which could dilute Press Ventures' market share.
- Market sentiment remains cautious, with some investors worried about the broader economic environment affecting consumer spending.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
PVEN Latest News
No recent news available for PVEN.
Leadership: Edward Denkiewicz
CEO
Edward Denkiewicz is the Chief Executive Officer of Press Ventures, Inc. His background includes experience in business development and technology commercialization. Prior to joining Press Ventures, Denkiewicz held various leadership positions in the technology sector, focusing on bringing innovative products to market. He has a strong understanding of intellectual property management and strategic partnerships.
Track Record: Since becoming CEO, Edward Denkiewicz has focused on securing the patent rights for the CLO-D technology and establishing a distribution network in Poland. He has also overseen the development of the company's marketing strategy and the initial commercialization efforts. His leadership is crucial for navigating the challenges of a small company in a competitive market.
PVEN OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Press Ventures, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial disclosure and may be subject to greater risks due to less stringent regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier requires a higher degree of due diligence and risk assessment.
- OTC Tier: OTC Other
- Limited financial disclosure increases information asymmetry.
- Low trading volume and liquidity can lead to price volatility.
- Higher risk of fraud or manipulation compared to listed exchanges.
- OTC Other tier status indicates potential financial or operational challenges.
- Shell Risk Detected indicates the potential for the company to be a shell corporation.
- Verify the company's legal status and registration.
- Obtain and review any available financial statements.
- Assess the company's management team and their experience.
- Research the CLO-D technology and its effectiveness.
- Evaluate the company's distribution network and market reach.
- Determine the company's compliance with OTC regulations.
- Investigate the Shell Risk Detected and its potential implications.
- Patented CLO-D technology provides some validation.
- Established distribution network in Poland.
- CEO with experience in technology commercialization.
- Focus on a specific niche market (air purification).
Press Ventures, Inc. Basic Materials Stock: Key Questions Answered
What happened to Press Ventures, Inc. (PVEN) stock?
Press Ventures, Inc. (PVEN) no longer trades on public markets. It was delisted in January 2026. The figures below are historical and are not a current quote.
Can I still buy PVEN shares?
No. PVEN stopped trading on public markets in January 2026, so the shares are not available through a broker. Anything you see quoted for PVEN elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before PVEN stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Press Ventures, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Press Ventures, Inc. do?
Press Ventures, Inc. owns the rights to and aims to commercialize the cedar leaf oil diffusion (CLO-D) technology in Poland. This patented technology converts cedar leaf oil into a vapor, which is then diffused to kill bacteria, mold, and viruses.
What do analysts say about PVEN stock?
There is currently no available analyst coverage for PVEN stock. Given its OTC Other listing and limited financial disclosure, it is unlikely that major brokerage firms or research institutions provide in-depth analysis. Investors should rely on their own due diligence and risk assessment when considering an investment in Press Ventures, Inc. Key metrics to monitor include revenue growth, market share, and progress in securing partnerships with HVAC manufacturers.
What are the main risks for PVEN?
The main risks for Press Ventures, Inc. include its limited financial resources, dependence on air conditioning installation companies for distribution, and competition from established air purification companies. The company's OTC Other tier status and unknown disclosure level also pose significant risks, as investors may lack access to reliable financial information.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial information available for Press Ventures, Inc.
- OTC Other tier status indicates higher risk.
- AI analysis pending for PVEN.